成都纽瑞特医疗科技股份有限公司 is a pharmaceuticals company based out of 成都, 四川, China. Founded in 2016, the company operates in the Biotechnology, Health Care, and Manufacturing industries. In its latest funding round on 14 March 2024, the company secured a significant CNY300.00M Series C investment. The investors participating in this round include Si Chuan Venture Capital, Star Capital, Chengdu Science and Technology Venture Capital, 成都天府国际生物城投资开发有限公司, Neovision Capital, and Huaxing Kangping.
成都纽瑞特医疗科技股份有限公司
Founded 2016
8 employees
Series C
Total: $516.00M
Biotechnology, Health Care +1
General Information
Company Name
成都纽瑞特医疗科技股份有限公司
Founded Year
2016
Employees
8
Industries
Biotechnology, Health Care, Manufacturing
Funding Stage
Series C
BounceWatch is an independent company data service, not affiliated with 成都纽瑞特医疗科技股份有限公司. To contact 成都纽瑞特医疗科技股份有限公司, visit nrtmedtech.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
About 成都纽瑞特医疗科技股份有限公司
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series C | CNY300.00M | 6 |
|
14 Mar 2024 |
| Series B | CNY116.00M | 3 |
|
17 Jul 2019 |
| Series A | CNY100.00M | 1 |
|
09 Oct 2018 |
成都纽瑞特医疗科技股份有限公司 Alternatives & Competitors
View All Alternatives
成都纽瑞特医疗科技股份有限公司 vs
Harbin Pharma is a pharmaceuticals company based out of HAERBIN, HNG, China.
Post-IPO Equity
15 employees
Biotechnology, Health Care
成都纽瑞特医疗科技股份有限公司 vs
MicuRx Pharmaceuticals, Inc.
United States
MicuRx Pharmaceuticals is a biotechnology company based out of Foster City, California USA and Shang...
Series E
26 employees
Biotechnology, Health Care
成都纽瑞特医疗科技股份有限公司 vs
Jiangzhong Pharma is a pharmaceuticals company based out of NANCHANG, JGX, China.
Venture round
254 employees
Biotechnology, Manufacturing
FAQ About 成都纽瑞特医疗科技股份有限公司
成都纽瑞特医疗科技股份有限公司 is a pharmaceuticals company based out of 成都, 四川, China.
成都纽瑞特医疗科技股份有限公司 was founded in 2016.
成都纽瑞特医疗科技股份有限公司 operates in Biotechnology, Health Care and Manufacturing.
成都纽瑞特医疗科技股份有限公司 has approximately 8 employees.
成都纽瑞特医疗科技股份有限公司 has completed 3 funding rounds, raising a total of $516.00M. The latest funding stage is Series C.
Top alternatives and competitors to 成都纽瑞特医疗科技股份有限公司 include Harbin Pharmaceutical Group Co., Ltd., MicuRx Pharmaceuticals, Inc., Jiangzhong Pharmaceutical Co., Ltd., Zhejiang Xianju Pharmaceutical Co., Ltd., 山东英盛生物技术有限公司. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
成都纽瑞特医疗科技股份有限公司 and Harbin Pharmaceutical Group Co., Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for 成都纽瑞特医疗科技股份有限公司, https://bouncewatch.com/company/-3606, updated 27 December 2024. When citing, please name BounceWatch and link this page.
